title: Nelfinavir plasma concentrations in patients experiencing early failure with nelfinavir-containing triple combinations.
authors.affiliation: Pharmacology Unit, Hospital Carlos III, Instituto de Salud Carlos III, Madrid, Spain.
authors.forename: Daniel
authors.initials: D
authors.lastname: Gonzàlez de Requena
authors.forename: Marina
authors.initials: M
authors.lastname: Núñez
authors.forename: Carmen
authors.initials: C
authors.lastname: de Mendoza
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Jiménez-Nàcher
authors.forename: Vincent
authors.initials: V
authors.lastname: Soriano
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D024882:Drug Resistance, Viral / Q000235:genetics; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000097:blood* / Q000627:therapeutic use; D006801:Humans; D019888:Nelfinavir / Q000097:blood* / Q000627:therapeutic use; D012008:Recurrence; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D017211:Treatment Failure
chemical_list: D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019888:Nelfinavir